Poulvac Maternavac* IBD-Reo (Canada)

Company: Zoetis

Bursal Disease-Reovirus Vaccine

Standard and Variant, Killed Virus

For Veterinary Use Only

For the revaccination of healthy chickens as an aid in the prevention of the signs and lesions associated with infectious bursal disease caused by standard and variant strains and avian reovirus infections which cause malabsorption syndrome. As an aid for the prevention of signs and lesions associated with infectious bursal disease and reovirus disease via maternal antibodies in the progeny of vaccinates.

DOSE: Inject 0.5 mL (0.5 cc) intramuscularly or subcutaneously (in the lower neck region) using aseptic technique. Vaccinate only healthy birds. For primed birds, a single dose between 16 and 22 weeks (approximately 4 weeks prior to lay) is indicated.

Poulvac Maternavac* IBD-Reo Caution

Store in the dark at 2° to 7°C (35° to 45°F). Do not freeze. Warm to 22°C (72°F) and shake well before using. Do not vaccinate within 42 days before slaughter. Use entire contents when first opened.

Gentamicin and amphotericin B added as preservatives.

Warning

In case of accidental human injection seek immediate medical attention.

U.S. Vet. License No. 190

Zoetis Inc., Kalamazoo, MI 49007, USA

CPN: 1198437.2